Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

1 marketed ·

Quick facts

Marketed products

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

What are Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics's marketed drugs?

Top marketed products include Placebo (Capsule/Tablet).

Related